Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
Actual shortage: | 212 (7%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 2706 (92%) | |
Discontinuation Reports |
300 |
|
To be discontinued: | 2 (1%) | |
Discontinued: | 298 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
362 (11%) |
|
Overdue reports |
85 (40%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
ACT RALOXIFENE | 60MG | TABLET | Resolved | 2020-10-22 | 2020-11-26 | 126909 |
ACT RALOXIFENE | 60MG | TABLET | Resolved | 2021-01-22 | 2021-05-06 | 132276 |
ACT RANITIDINE | 150MG | TABLET | Resolved | 2019-06-18 | 2019-08-06 | 86927 |
ACT RANITIDINE | 300MG | TABLET | Resolved | 2017-03-17 | 2017-09-19 | 3320 |
ACT RANITIDINE | 150MG | TABLET | Resolved | 2019-09-26 | 2020-05-14 | 94846 |
ACT RANITIDINE | 150MG | TABLET | Resolved | 2019-09-26 | 2020-05-14 | 94849 |
ACT RANITIDINE | 150MG | TABLET | Resolved | 2019-09-26 | 2020-05-14 | 94852 |
ACT RANITIDINE | 300MG | TABLET | Resolved | 2019-09-26 | 2020-05-14 | 94855 |
ACT RANITIDINE | 150MG | TABLET | Resolved | 2020-01-24 | 2020-05-14 | 104307 |
ACT REPAGLINIDE | 0.5MG | TABLET | Actual shortage | 2021-11-18 | 2021-11-18 | 149591 |
ACT REPAGLINIDE | 1MG | TABLET | Actual shortage | 2021-11-18 | 2021-11-18 | 149596 |
ACT REPAGLINIDE | 2MG | TABLET | Actual shortage | 2021-11-18 | 2021-11-18 | 149606 |
ACT RIZATRIPTAN | 10MG | TABLET | Resolved | 2019-09-05 | 2019-10-17 | 93169 |
ACT RIZATRIPTAN | 10MG | TABLET | Resolved | 2024-05-09 | 2025-04-28 | 227492 |
ACT RIZATRIPTAN | 10MG | TABLET | Resolved | 2024-07-04 | 2025-04-28 | 232235 |
ACT RIZATRIPTAN | 10MG | TABLET | Resolved | 2020-05-29 | 2020-06-04 | 116135 |
ACT RIZATRIPTAN | 10MG | TABLET | Resolved | 2017-05-24 | 2017-09-19 | 10988 |
TEVA-ROPINIROLE | 0.25MG | TABLET | Resolved | 2019-10-17 | 2020-04-02 | 96714 |
TEVA-ROPINIROLE | 1MG | TABLET | Resolved | 2020-01-30 | 2020-06-11 | 104908 |
TEVA-ROPINIROLE | 0.25MG | TABLET | Resolved | 2020-05-01 | 2020-08-17 | 113779 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256146 |
TEVA-VALSARTAN | 80MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256149 |
TEVA-VALSARTAN | 160MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256152 |
TEVA-VALSARTAN | 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256155 |
TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
TEVA-VORICONAZOLE | 50MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256169 |
VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |